Scar Tissue Formation: Site Rotation Best Practices

This guide covers how lipohypertrophy develops, how to prevent it with proper site rotation, how to identify existing lipohypertrophy, and how to reverse it through strategic site management.

Lipohypertrophy is the enlargement of fat cells at repeated injection sites. It appears as firm, thickened tissue, often with visible bumps or lumps. The affected area may feel hardened or nodular (bumpy) when touched.

The condition is not dangerous in itself, but it indicates tissue damage and can create practical problems: lipohypertrophic sites can become uncomfortable to inject, may develop uneven medication absorption, and cosmetically may be noticeable if the injection area is visible (abdomen, thighs, arms).

Mechanical trauma: Repeated needle penetration in the same spot causes cumulative tissue damage, inflammation, and scar tissue formation. Each injection creates a small wound that normally heals within days. But repeated injections in the same spot before complete healing means wounds are constantly being re-opened, preventing healing.

Metabolic effect of the medication: Many peptides have lipogenic effects—they promote the growth and enlargement of fat cells. Repeated exposure of the same fat cells to lipogenic peptides causes those cells to grow abnormally large, sometimes reaching nearly twice the size of normal fat cells.

The combination of mechanical trauma plus the lipogenic effect of many peptides creates the ideal environment for lipohypertrophy development.

Reusing needles: A dull needle (from reuse) causes more tissue trauma than a sharp needle, dramatically increasing lipohypertrophy risk.